Liquidmetal® Technologies, Inc. (OTCQB: LQMT), the world's leading developer of amorphous alloys, announced today that it has received a production order for an innovative medical device component.
"Our emerging partnership with medical products developer, CoNextions Medical, is demonstrating the advanced capabilities of both businesses and paving the way for the delivery of an innovative medical device." said Tom Steipp, CEO of Liquidmetal Technologies. "Our collaborative engineering design efforts have yielded a manufacturing solution for a key medical device component based on the principle values of the Liquidmetal materials and molding technology."
"CoNextions Medical current focus is on providing a superior alternative to suture-based tendon repairs. The ability to mold complex metal shapes with highly impressive material properties in a single process step, has provided an important manufacturing solution for our medical device," said Richard J. Linder, President and CEO of CoNextions Medical. "I am excited about the progress our two organizations have made together and we look forward to working with Liquidmetal Technologies."
www.liquidmetal.com
